FOLH1 and posterior cortical atrophy: The good diagnostic performance of PSMA-targeted tracers and the high tumor expression of PSMA in advanced PCa have facilitated the investigation of radiotherapeutics that target PSMA, such as [177Lu]Lu-PSMA617 and [225Ac]Ac-PSMA617 [124,125,126].